Real-World Economic Impact of OnabotulinumtoxinA in Patients With Chronic Migraine

OBJECTIVE: To determine whether the utilization of healthcare resources is reduced after chronic migraine patients are treated for 6 months with onabotulinumtoxinA. BACKGROUND: OnabotulinumtoxinA is indicated for headache prophylaxis in patients with chronic migraine, but its effect on healthcare re...

Descripción completa

Detalles Bibliográficos
Autores principales: Rothrock, John F, Bloudek, Lisa M, Houle, Timothy T, Andress-Rothrock, Diane, Varon, Sepideh F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Research Submissions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282490/
https://www.ncbi.nlm.nih.gov/pubmed/25298117
http://dx.doi.org/10.1111/head.12456

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282490/
https://www.ncbi.nlm.nih.gov/pubmed/25298117
http://dx.doi.org/10.1111/head.12456

Ejemplares similares